Australia GMP BIO Pharmaceuticals

What Australia GMP BIO Pharmaceuticals does

Australia GMP BIO Pharmaceuticals Pty Ltd (AGB) is a privately held, TGA GMP licensed contract manufacturer based in Auburn, New South Wales, specializing in the formulation, production, and packaging of natural health products, complementary medicines, nutritional supplements, cosmetics, and functional foods. The company operates from a single purpose-built facility at Unit A 11-13 Short Street, Auburn, equipped with separate storage, manufacturing, and packaging areas, air filtration systems, and a comprehensive quality management framework built on SOPs, barcode tracking, and electronic material movement systems. Production capabilities span multiple dosage formats — capsules (1M+ per day capacity), tablets, powders (up to 20,000kg/day), liquids, sachets, softgel, hard shell, creams, and gels — with batch sizes ranging from 10kg to 1,300kg, enabling both small production runs for emerging brands and large-scale runs for established clients.

The company offers an integrated service stack covering formulation development by in-house R&D scientists, GMP-compliant manufacturing, automated and manual packaging, labelling, and third-party laboratory testing, with operations audited regularly by independent certifying organizations under PIC/S international standards. AGB serves brands and companies in Australia, Asia, USA, EU and other international markets through a direct B2B sales-led model, providing tailored quotes and personalized consultation for each project rather than standardized pricing.

Revenue is generated through transaction-based contract manufacturing fees tied to order volume, complexity, and specifications, supplemented by formulation development and consulting services. The company employs a full-time training coordinator and experienced production supervisors to maintain GMP compliance, and maintains a horizontal customer base across the nutritional supplement, cosmetic, and functional food sectors. The company is owner-operated with no disclosed institutional investors, funding rounds, or parent entity, and serves its markets through direct client relationships rather than intermediaries.

Name

Australia GMP BIO Pharmaceuticals

Legal name

Australia GMP BIO Pharmaceuticals Pty Ltd

Website

https://ausgmppharma.com.au

Company type

Private

Operating status

Operating

Ownership category

akta.pro rank

Product category

Nutraceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Food And Kindred Products (2000)

akta.pro primary industry

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

akta.pro secondary industry

GMP Manufacturing Support Services (QA/QMS, validation, documentation) (HLAAAKAH)

Keywords

• Nutraceutical contract manufacturing
• Supplement manufacturing services
• Complementary medicine production
• Pharmaceutical packaging services
• Functional food manufacturing

Headquarters

HQ city

Auburn

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Contract Manufacturing Services: Full-service contract manufacturing of natural health products and supplements. Clients pay for custom formulation, production, and packaging services based on their specifications. Revenue is generated through production fees, with pricing based on order volume, complexity, and specific manufacturing requirements.
2. Formulation Development: Research and development services for creating new supplement formulas, including taste optimization, stability testing, and shelf-life determination. These services are bundled with manufacturing or provided as standalone consulting.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Australia GMP BIO Pharmaceuticals provides B2B contract formulation, development, manufacturing, blending, packaging, and labeling for natural health products, supplements, complementary medicines, cosmetics, and functional foods. Its Auburn facility supports capsules, tablets, powders, liquids, sachets, creams, and gels for client brands, with GMP-compliant production and quality control.

Product overview

Australia GMP BIO Pharmaceuticals (AGB) is a full-service contract manufacturer of natural health products and complementary medicines. The company offers a comprehensive suite of manufacturing solutions spanning capsules, tablets, powder supplements, liquid supplements, sachets, and functional foods. Manufacturing capabilities include blending services with batch sizes from 10kg to 1,300kg and powder production up to 20,000kg per day. The company provides complete packaging and labelling services through both automated packaging lines and manual packaging operations. All operations are conducted under TGA GMP and PIC/S compliance standards.

Differentiator

Problem solved

Functional benefit

Products and services

• Formulation Development
• Capsules
• Tablets
• Powder Supplements
• Liquid Supplements
• Sachets
• Functional Foods
• Creams and Gels
• Blending Services
• Packaging and Labelling Services

Quantifiable outcome

• Over 1 million capsules produced per day
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Factors Group of Companies: Canadian contract manufacturer of natural health products, supplements, and functional foods operating GMP-compliant facilities. Direct competitor to AGB offering similar dosage formats (capsules, tablets, powders, liquids) and contract manufacturing services to brand customers in regulated markets with comparable scale and full-service model.
• Robinson Pharma: US-based supplement contract manufacturer producing capsules, tablets, softgels, and powders under cGMP standards. Comparable to AGB in serving supplement brand customers with full-service contract manufacturing capabilities, particularly competing for mid-sized brand customers seeking flexible production runs.
• Makers Nutrition: US-based full-service supplement contract manufacturer offering capsules, tablets, powders, and liquid manufacturing under GMP certification. Direct competitor to AGB for international supplement brand customers, particularly those seeking smaller production runs and custom formulation services.
• Vitakem: US supplement contract manufacturer producing capsules, tablets, powders, and gummies under cGMP standards. Similar mid-sized B2B contract manufacturer to AGB serving nutritional supplement brands with regulatory-compliant manufacturing and flexible order quantities.

Broad incumbents

• Catalent: Global CDMO with extensive contract manufacturing capabilities across multiple dosage forms including softgel, oral solids, and liquids. Larger incumbent with broader capabilities than AGB but includes nutraceutical manufacturing services that compete for the same brand customers, particularly larger-volume contracts.
• Thermo Fisher Scientific (Patheon): Global pharmaceutical services and CDMO through its Patheon business, offering contract manufacturing across pharmaceuticals and consumer health products. Larger-scale competitor that AGB could compete with for larger supplement brand contracts needing extensive capabilities and geographic reach.
• Blackmores: Leading Australian vitamin and supplement brand that operates its own TGA GMP manufacturing facilities. While primarily a brand, its in-house manufacturing represents an alternative to outsourcing at AGB and competes for industry talent and expertise in the Australian nutraceutical market.
• Lonza: Global CDMO with contract manufacturing services spanning pharmaceuticals, biologics, and consumer health including nutrition. Larger incumbent competing for premium brand customers needing highly regulated manufacturing partners, particularly those with global distribution requirements.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/AusGMP
• LinkedInlinkedin.com/company/australia-gmp-bio-pharmaceuticals

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australia GMP BIO Pharmaceuticals